#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glomerulonephritis minimal lesion Encephalopathy neonatal Hypotransferrinaemia Leber's congenital amaurosis Kaposi's sarcoma ROHHAD syndrome Penile cancer Adrenocortical carcinoma Graft versus host disease Astrocytoma malignant Haematological malignancy Erythema multiforme Heavy menstrual bleeding Arterial disorder Giant cell tumour of tendon sheath More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia – Diagnostics Glomerulonephritis rapidly progressive – Treatment Behcet’s syndrome – Diagnostics Loeys-Dietz syndrome – Treatment Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Hereditary motor and sensory neuropathy – Life with Disease Antithrombin III deficiency Anaplastic thyroid cancer – Treatment Short-bowel syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSKVX000000030918 Ttf-Ngr Vericiguat ARI0008 ADS-019 Trientine Dihydrochloride Deoxyribonucleic Acid Pabinafusp Alfa Mbf-015 Cpk850 Folic Acid, Anhydrous Sodium Chloride Clobetasol Df1001 Isis 696844 Isotretinoin Ibrutinib Coffee Charcoal Dutasteride Disulfiram More therapies…

    Learn about Your Condition

    Hydrocele Pustular psoriasis Meningioma malignant Rectal cancer Osteosarcoma metastatic Juvenile absence epilepsy Pancreatic carcinoma recurrent Hypoparathyroidism Aplasia pure red cell Pyoderma gangrenosum Monogenic diabetes Acute respiratory failure Mitral valve disease Rectal cancer stage II Cholangiocarcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of NIDO-361 for Patients with Spinal and Bulbar Muscular Atrophy (SBMA)

    Not recruiting

    2 1
    Investigated Diseases:
    • Bulbospinal muscular atrophy congenital
    Investigated Drugs:
    • Nido-361
    Denmark Italy

  • Study on Bepranemab for Patients with Early Alzheimer’s Disease

    Not recruiting

    2 1 1
    Investigated Drugs:
    • 2-(4-(2-[18F]FLUORO-2,2-DIDEUTERO ETHYL)PIPERIDIN-1-YL)BENZO[4,5]IMIDAZO[1,2-A]PYRIMIDINE
    • Bepranemab
    • Florbetaben (18F)
    Belgium France Germany Italy The Netherlands Poland +1

  • Study on How Concizumab Works for Patients with Hemophilia A or B Without Inhibitors

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    • Factor IX deficiency
    Investigated Drugs:
    • Concizumab
    Denmark Estonia France Germany Hungary Italy +5

  • Study Comparing Abemaciclib and Fulvestrant with Placebo and Fulvestrant for Patients with Advanced or Metastatic Breast Cancer After Previous Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Breast neoplasm
    Investigated Drugs:
    • Abemaciclib
    • Fulvestrant
    Belgium Czechia Denmark France Greece Hungary +3

  • Study on MK-2870 for Patients with Endometrial Cancer After Platinum and Immunotherapy Treatment

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Sacituzumab Tirumotecan
    • Caffeine
    • Acetylsalicylic Acid
    Austria Belgium Czechia Denmark Finland France +9

  • Study of Pembrolizumab, Lenvatinib, and Belzutifan for Patients with Renal Cell Carcinoma

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Quavonlimab
    • Favezelimab
    • Mk-4830
    France Hungary The Netherlands Poland Spain
Previous Page
1 … 1,665 1,666 1,667 1,668 1,669 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!